Ivo Hanke

Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study

E. Novotná, J. Hofman, T. Rozkoš, 2022, International journal of molecular sciences.

Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo

J. Hofman, T. Rozkoš, Yu Zhang, 2022, Pharmaceutics.

XML-Based Authoring: from Concepts via Compromises to Applications

Wolf Bubenik, Ivo Hanke, Nadia Juhnke, 2005, ELPUB.

Lung Cancer in the Czech Republic.

L. Dušek, R. Matěj, N. Pauk, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo.

E. Novotná, J. Hofman, T. Rozkoš, 2023, Biochemical pharmacology.

Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo

E. Novotná, J. Hofman, J. Küpper, 2021, International journal of molecular sciences.